Rns Pharmaceuticals Pvt Ltd

Rns Pharmaceuticals Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U51397MH2006PTC163984 Incorporated 23 August 2006 ROC Mumbai HQ Mumbai, Maharashtra, India
Struck Off Private Limited Company pharma
Data last updated
Revenue · FY 2021
-
Latest filing
EBITDA · FY 2021
*****
▲ 58.33% YoY
Net profit · FY 2021
*****
▲ 58.94% YoY
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
None
Satisfied ₹2 Cr
Company age
20 yrs
Est. 2006
Last financials
Mar 2021
Balance sheet date

About Rns Pharmaceuticals Pvt Ltd

Data last updated: 26 July 2025

Rns Pharmaceuticals Pvt Ltd was a private limited company based in Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It specialised in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 23 August 2006.

Registered with ROC Mumbai under CIN U51397MH2006PTC163984.

Capital: an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was led by directors including Vasant Ganpat Chavan and Mukesh Harkishandas Chitalia.

Last AGM: 30 November 2021. Financial statements filed for year ended 31 March 2021. Office: Shop No. 10 Girnar Bldg 69 Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034.

As per MCA filings, the company had satisfied charges of ₹2 Cr on record.

The company is no longer operational and has been struck off from the Register of Companies, typically due to non-filing of annual returns or failure to commence business. Entering into any agreement with a struck-off entity carries significant legal and financial risk.

Company Details of Rns Pharmaceuticals Pvt Ltd
CIN U51397MH2006PTC163984
Registration Number 163984
Incorporation Date 23 August 2006
ROC Mumbai
Listing Status Unlisted
Company Status Struck Off
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
Key People
Vasant Ganpat Chavan Director Mukesh Harkishandas Chitalia Director Mohan Ganpat Chavan Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    Shop No. 10 Girnar Bldg 69 Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Rns Pharmaceuticals Pvt Ltd - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Rns Pharmaceuticals Pvt Ltd report

Financials, compliance, directors, charges, ownership and filings for Rns Pharmaceuticals Pvt Ltd in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Rns Pharmaceuticals Pvt Ltd

Rns Pharmaceuticals Pvt Ltd operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Manufacturing ********* Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products *********

Auditor Details of Rns Pharmaceuticals Pvt Ltd

Rns Pharmaceuticals Pvt Ltd is audited by K R MANIK & CO for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
K R MANIK & CO blur-value blur-value blur-value

Board of Directors of Rns Pharmaceuticals Pvt Ltd

Rns Pharmaceuticals Pvt Ltd is governed by 5 directors who oversee the company's operations and strategic decisions.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Vasant Ganpat Chavan
Also directs: Indravati Hospital & Research Centre Llp, Rahul Distributors Private Limited, Ipc Healthcare Private Limited and 1 more
Director 23 Aug 2006 19 Years 10 Months As last reported
Mukesh Harkishandas Chitalia Director 23 Aug 2006 19 Years 10 Months As last reported
Mohan Ganpat Chavan
Also directs: Rahul Distributors Private Limited, Ipc Healthcare Private Limited, Rahul Welfare Foundation and 4 more
Director 23 Aug 2006 19 Years 10 Months As last reported
Ankit Pankaj Parekh
Also directs: Krutishil Distributors Private Limited, Sainath Agencies (Pharma) Private Limited
Director 23 Aug 2006 19 Years 10 Months As last reported
Binoy Pankaj Parekh
Also directs: Krutishil Distributors Private Limited, Sainath Agencies (Pharma) Private Limited
Director 23 Aug 2006 19 Years 10 Months As last reported
View all directors

Financials of Rns Pharmaceuticals Pvt Ltd FY 2021 filings available

Rns Pharmaceuticals Pvt Ltd reported revenue of ₹- (up ) for FY 2021. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
-
Profit
***** ▲ 58.94%
EBITDA
***** ▲ 58.33%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Rns Pharmaceuticals Pvt Ltd

As of FY 2021, Rns Pharmaceuticals Pvt Ltd's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Charges & Borrowings of Rns Pharmaceuticals Pvt Ltd

Open charges
₹0
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Axis Bank Limited₹2.00 Cr
Latest charge details
DateLenderAmountStatus
17 Nov 2014 Axis Bank Limited ₹1 Cr Satisfied
27 Sep 2014 Axis Bank Limited ₹1 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Rns Pharmaceuticals Pvt Ltd

View historical data on people associated with Rns Pharmaceuticals Pvt Ltd, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Rns Pharmaceuticals Pvt Ltd

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Rns Pharmaceuticals Pvt Ltd

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Rns Pharmaceuticals Pvt Ltd

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Rns Pharmaceuticals Pvt Ltd

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Rns Pharmaceuticals Pvt Ltd

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Rns Pharmaceuticals Pvt Ltd

MSME Payment Delays by Rns Pharmaceuticals Pvt Ltd

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Rns Pharmaceuticals Pvt Ltd

Subsidiaries & Group Companies of Rns Pharmaceuticals Pvt Ltd

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Rns Pharmaceuticals Pvt Ltd with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Rns Pharmaceuticals Pvt Ltd

MCA Filings & Documents of Rns Pharmaceuticals Pvt Ltd

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Rns Pharmaceuticals Pvt Ltd

Charges
19 Apr 2022
A charge registered on 17 Nov 2014 via Charge ID 10535623 with Axis Bank Limited was fully satisfied on 19 Apr 2022.
Charges
19 Apr 2022
A charge registered on 27 Sep 2014 via Charge ID 10525964 with Axis Bank Limited was fully satisfied on 19 Apr 2022.
Activity
30 Nov 2021
Rns Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Activity
31 Mar 2021
Rns Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.
Charges
17 Nov 2014
A charge with Axis Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 10535623 was registered on 17 Nov 2014.
Charges
27 Sep 2014
A charge with Axis Bank Limited amounted to Rs. 100.00 Lakh with Charge ID 10525964 was registered on 27 Sep 2014.

Frequently Asked Questions about Rns Pharmaceuticals Pvt Ltd

Rns Pharmaceuticals Pvt Ltd has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Rns Pharmaceuticals Pvt Ltd is a struck-off private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 23 August 2006 and is registered under CIN U51397MH2006PTC163984. The company has been struck off by the Registrar of Companies and is no longer operational.

The current directors of Rns Pharmaceuticals Pvt Ltd are:

The CIN (Corporate Identification Number) of Rns Pharmaceuticals Pvt Ltd is U51397MH2006PTC163984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Rns Pharmaceuticals Pvt Ltd is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company was active in this sector before being struck off.

The company has its registered office at Shop No. 10 Girnar Bldg 69 Tardeo Road Tardeo, Mumbai, Maharashtra, India – 400034.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available